Literature DB >> 27634117

Clinical Implications of Complete Left-Sided Reverse Remodeling With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy.

Andrew Mathias1, Arthur J Moss1, Scott McNitt1, Wojciech Zareba1, Ilan Goldenberg1, Scott D Solomon2, Valentina Kutyifa3.   

Abstract

BACKGROUND: Clinical implications of complete left-sided reverse remodeling due to cardiac resynchronization therapy with a defibrillator (CRT-D), defined as reduction in both left ventricular end-systolic volume (LVESV) and left atrial volume (LAV), are unknown.
OBJECTIVES: This study aimed to evaluate the rate and predictive value of complete left-sided reverse remodeling on heart failure (HF) and death events in CRT-D patients with left bundle branch block (LBBB) enrolled in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
METHODS: The study population comprised 533 CRT-D patients with LBBB, 212 (40%) with complete left-sided reverse remodeling (above-median change in both LAV and LVESV), 115 (22%) with discordant reverse remodeling (above-median change in only LAV or LVESV), and 206 (38%) with lesser reverse remodeling (below-median LAV and LVESV change). The primary endpoint was HF or death; secondary endpoints included HF alone and death alone during long-term follow-up.
RESULTS: Patients with complete left-sided reverse remodeling had a significantly lower rate of HF or death than those with discordant reverse remodeling or lesser reverse remodeling (p < 0.001). Multivariate Cox proportional hazard models consistently showed a decreased risk for HF and death in patients with complete reverse remodeling compared with discordant reverse remodeling or lesser reverse remodeling (hazard ratio: 0.66 per each group; 95% CI: 0.50 to 0.85; p = 0.002). This finding was similar for HF alone and death alone.
CONCLUSIONS: In MADIT-CRT, >20% of CRT-D patients exhibited discordant reverse remodeling in the left ventricle and the left atrium. CRT-D patients with LBBB and complete left-sided reverse remodeling had a significantly lower risk of HF and death, HF alone, and death alone during long-term follow-up than patients with discordant or lesser reverse remodeling. (MADIT-CRT: Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy [MADIT-CRT]; NCT00180271).
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial remodeling; bundle branch block; heart failure; outcomes; ventricular remodeling

Mesh:

Year:  2016        PMID: 27634117     DOI: 10.1016/j.jacc.2016.06.051

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

Review 1.  Reverse Cardiac Remodeling and ARNI Therapy.

Authors:  Andrew Abboud; James L Januzzi
Journal:  Curr Heart Fail Rep       Date:  2021-01-22

Review 2.  The Role for Cardiovascular Remodeling in Cardiovascular Outcomes.

Authors:  Nishant Krishna Sekaran; Anna Lisa Crowley; Fernanda Rodrigues de Souza; Elmiro Santos Resende; Sunil V Rao
Journal:  Curr Atheroscler Rep       Date:  2017-05       Impact factor: 5.113

Review 3.  Adverse Remodeling and Reverse Remodeling After Myocardial Infarction.

Authors:  Ankeet S Bhatt; Andrew P Ambrosy; Eric J Velazquez
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

Review 4.  Should Primary Prevention ICDs Still Be Placed in Patients with Non-ischemic Cardiomyopathy? A Review of the Evidence.

Authors:  Harsha V Ganga; Abhishek Maan; E Kevin Heist
Journal:  Curr Cardiol Rep       Date:  2018-03-24       Impact factor: 2.931

5.  Effect of single ventricular premature contractions on response to cardiac resynchronization therapy.

Authors:  Annamária Kosztin; Béla Merkely; Eperke Dóra Merkel; András Mihaly Boros; Walter Richárd Schwertner; Anett Behon; Attila Kovács; Bálint Károly Lakatos; László Gellér
Journal:  BMC Cardiovasc Disord       Date:  2022-06-25       Impact factor: 2.174

6.  Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.

Authors:  Kenneth M Borow; Alex Yaroshinsky; Barry Greenberg; Emerson C Perin
Journal:  Circ Res       Date:  2019-07-18       Impact factor: 17.367

7.  Left ventricular response after cardiac resynchronization therapy is related to early left atrial volume reduction.

Authors:  In-Jeong Cho; Jae-Sun Uhm; Jaewon Oh; Jong-Ho Nam; Hee Tae Yu; Taehoon Kim; Boyoung Joung; Seok-Min Kang
Journal:  Korean J Intern Med       Date:  2020-02-06       Impact factor: 2.884

8.  Impact of anatomical reverse remodelling in the design of optimal quadripolar pacing leads: A computational study.

Authors:  Cristobal Rodero; Marina Strocchi; Angela W C Lee; Christopher A Rinaldi; Edward J Vigmond; Gernot Plank; Pablo Lamata; Steven A Niederer
Journal:  Comput Biol Med       Date:  2021-11-25       Impact factor: 4.589

9.  The impact of menopausal hormone therapy (MHT) on cardiac structure and function: Insights from the UK Biobank imaging enhancement study.

Authors:  Mihir M Sanghvi; Nay Aung; Jackie A Cooper; José Miguel Paiva; Aaron M Lee; Filip Zemrak; Kenneth Fung; Ross J Thomson; Elena Lukaschuk; Valentina Carapella; Young Jin Kim; Nicholas C Harvey; Stefan K Piechnik; Stefan Neubauer; Steffen E Petersen
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

Review 10.  Latest Insights into Mechanisms behind Atrial Cardiomyopathy: It Is Not always about Ventricular Function.

Authors:  Bianca-Ana Dmour; Radu-Stefan Miftode; Dan Iliescu Halitchi; Dana Teodora Anton-Paduraru; Codruta-Olimpiada Iliescu Halitchi; Ionela-Larisa Miftode; Ovidiu Mitu; Alexandru-Dan Costache; Celina-Silvia Stafie; Irina Iuliana Costache
Journal:  Diagnostics (Basel)       Date:  2021-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.